Puravankara share price has plunged 4% and is presently trading at Rs 346.8.
Meanwhile, the BSE REALTY index is at 7,421.6 (up 1.4%).
Among the top losers in the BSE REALTY index today is MAHINDRA LIFESPACE (down 1.3%).
OBEROI REALTY (up 3.0%) and DLF (up 1.5%) are among the top gainers today.
Over the last one year, Puravankara has moved up from Rs 152.4 to Rs 346.8, registering a gain of Rs 194.4 (up 127.6%).
On the other hand, the BSE REALTY index has moved up from 5,271.5 to 7,421.6, registering a gain of 40.8% during the last 12 months.
The top gainers among the BSE REALTY index stocks during this same period were Sobha (up 91.8%), PRESTIGE ESTATES (up 76.3%) and OBEROI REALTY (up 57.0%).
For Investors: Our Big Prediction
The BSE Sensex is at 77,517.4 (down 0.2%).
The top losers among the BSE Sensex today are ITC (down 2.1%) and Hindustan Unilever (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,525.0 (down 0.1%). BPCL and Hindustan Unilever are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,517.4, registering a gain of 12,257.9 points (up 18.8%).
Puravankara net profit fell 169.2% YoY to Rs -249 million for the quarter ended September 2024, compared to a loss of Rs 93 million a year ago. Net sales rose 34.5% to Rs 4,955 million during the period as against Rs 3,683 million in July-September 2023.
For the year ended March 2024, Puravankara reported 36.9% decrease in net profit to Rs 420 million compared to net profit of Rs 665 million during FY23. Revenue of the company grew 76.8% to Rs 21,853 million during FY24.
The current Price to earnings ratio of Puravankara, based on rolling 12 month earnings, stands at 126.6.
Equitymaster requests your view! Post a comment on "Puravankara Plunges 4%; BSE REALTY Index Up 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!